-
1دورية أكاديمية
المؤلفون: Sahni, ManishAff1, IDs13193024019211_cor1, Goyal, Shefali, Devgarha, Sanjeev, Sisodiya, Anula
المصدر: Indian Journal of Surgical Oncology. 15(2):409-413
-
2دورية أكاديمية
المؤلفون: Kai Lei, Jia-Guo Wang, Yin Li, Hong-Xiang Wang, Jie Xu, Ke You, Zuo-Jin Liu
المصدر: Heliyon, Vol 9, Iss 8, Pp e18494- (2023)
مصطلحات موضوعية: Hepatocellular carcinoma (HCC), OS (overall survival), Prealbumin (PAB), Prognosis, Transcatheter arterial chemoembolisation (TACE), Science (General), Q1-390, Social sciences (General), H1-99
وصف الملف: electronic resource
-
3كتاب إلكتروني
المؤلفون: Fujiwara, YuAff3, Miyashita, HirotakaAff4, Galsky, Matthew D.Aff3
المساهمون: Stratton, Kelly L., editorAff1, Morgans, Alicia K., editorAff2
المصدر: Urologic Oncology : Multidisciplinary Care for Patients. :425-441
-
4دورية أكاديمية
المؤلفون: Huixin Zhang, Muoyan Xu, Jiashen Shao, Huifang Kong, Xudong Gao, Wei Zhang, Xiujuan Chang, Bin Yang, Yan Chen, Zheng Dong, Jiagan Huang, Zhen Zeng, Yongping Yang
المصدر: Frontiers in Oncology, Vol 13 (2023)
مصطلحات موضوعية: (LTP) local tumor progression, (OS) overall survival, (TFS) tumor-free survival, (HCC) hepatocellular carcinoma, (MRI) magnetic resonance imaging, (AFP) α-fetoprotein, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Jahangiri, Arman, Chin, Aaron T, Flanigan, Patrick M, Chen, Rebecca, Bankiewicz, Krystof, Aghi, Manish K
المصدر: Journal of Neurosurgery. 126(1)
مصطلحات موضوعية: Medical Biotechnology, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Orphan Drug, Neurosciences, Rare Diseases, Biotechnology, Cancer, Brain Cancer, Brain Disorders, 5.1 Pharmaceuticals, Development of treatments and therapeutic interventions, Animals, Brain Neoplasms, Convection, Drug Delivery Systems, Glioblastoma, Humans, convection enhanced delivery, glioblastoma, blood-brain barrier, oncology, BBB = blood-brain barrier, CED = convection-enhanced delivery, GDL = gadoteridol-loaded liposomes, HSV-TK = herpes simplex virus–thymidine kinase, IL-4 = interleukin-4, OS = overall survival, PFS = progression-free survival, TF = transferrin, TMZ = temozolomide, TRAIL = tumor necrosis factor–related apoptosis-inducing ligand, Clinical Sciences, Neurology & Neurosurgery, Clinical sciences
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/638993gb
-
6دورية أكاديمية
المؤلفون: Lau, Darryl, Magill, Stephen T, Aghi, Manish K
المصدر: Neurosurgical FOCUS. 37(6)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Rare Diseases, Brain Cancer, Brain Disorders, Orphan Drug, Cancer, Neurosciences, Evaluation of treatments and therapeutic interventions, Development of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 5.1 Pharmaceuticals, Brain Neoplasms, Glioblastoma, Humans, Molecular Targeted Therapy, Neoplasm Recurrence, Local, combination treatment, glioblastoma, molecular therapy, overall survival, progression-free survival, recurrent, BBB = blood-brain barrier, CR = complete response, EGFR = epidermal growth factor receptor, MGMT = methyguanine DNA methyltransferase, OS = overall survival, PD = progressive disease, PDGFR = platelet-derived growth factor receptor, PFS = progression-free survival, PKC = protein kinase C, PR = partial response, RTK = receptor tyrosine kinase, RTKI = RTK inhibitor, SD = stable disease, TCGA = The Cancer Genome Atlas, VEGF = vascular endothelial growth factor, VEGFR = VEGF receptor, mTOR = mammalian target of rapamycin, Clinical Sciences, Neurology & Neurosurgery
وصف الملف: application/pdf
URL الوصول: https://escholarship.org/uc/item/4nb66879
-
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8
المؤلفون: Frank Kolligs, Dirk Arnold, Rita Golfieri, Maciej Pech, Bora Peynircioglu, Thomas Pfammatter, Maxime Ronot, Bruno Sangro, Niklaus Schaefer, Geert Maleux, Graham Munneke, Helena Pereira, Bleranda Zeka, Niels de Jong, Thomas Helmberger, Thomas Albrecht, Olivier D’Archambeau, Tugsan Balli, Sadik Bilgic, Allan Bloom, Roberto Cioni, Roman Fischbach, Patrick Flamen, Laurent Gerard, Gerd Grözinger, Marcus Katoh, Michael Koehler, Jan Robert Kröger, Christiane Kuhl, Franco Orsi, Murat Özgün, Peter Reimer, Axel Schmid, Alessandro Vit
المساهمون: CIRT Principal Investigators, Albrecht, T., D'Archambeau, O., Balli, T., Bilgic, S., Bloom, A., Cioni, R., Fischbach, R., Flamen, P., Gerard, L., Grözinger, G., Katoh, M., Koehler, M., Kröger, J.R., Kuhl, C., Orsi, F., Özgün, M., Reimer, P., Ronot, M., Schmid, A., Vit, A., University of Zurich, de Jong, Niels
المصدر: JHEP reports, vol. 5, no. 2, pp. 100633
مصطلحات موضوعية: Hepatology, 10042 Clinic for Diagnostic and Interventional Radiology, 2724 Internal Medicine, 2723 Immunology and Allergy, Gastroenterology, Internal Medicine, Immunology and Allergy, 610 Medicine & health, 2721 Hepatology, 2715 Gastroenterology, ALBI, albumin-bilirubin, BCLC, Barcelona Clinic Liver Cancer, BSA, body surface area, CIRSE, Cardiovascular and Interventional Radiological Society of Europe, CIRT, CIRSE Registry for SIR-Spheres Therapy, ECOG, Eastern Cooperative Oncology Group, HCC, hepatocellular carcinoma, HR, hazard ratio, INR, international normalized ratio, IPTW, inverse probability of treatment weighting, OS, overall survival, PFS, progression-free survival, PVT, portal vein thrombosis, REILD, radioembolization-induced liver disease, SIRT, TACE, transcatheter arterial chemoembolization, TARE, transarterial radioembolization, Y90, Yttrium-90, dosimetry, hPFS, hepatic progression-free survival, liver, mBSA, modified body surface area, observational, radioembolization, registry
وصف الملف: application/pdf; PIIS2589555922002051.pdf - application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f66db9cadefae55cccd9dce8fea585c9
-
9
المؤلفون: Gianluca Ferini, Anna Viola, Vito Valenti, Antonella Tripoli, Laura Molino, Valentina Anna Marchese, Salvatore Ivan Illari, Giuseppina Rita Borzì, Angela Prestifilippo, Giuseppe Emmanuele Umana, Emanuele Martorana, Gianluca Mortellaro, Giuseppe Ferrera, Alberto Cacciola, Sara Lillo, Antonio Pontoriero, Stefano Pergolizzi, Silvana Parisi
المصدر: Clinical and Translational Radiation Oncology, Vol 32, Iss, Pp 52-58 (2022)
Clinical and Translational Radiation Oncologyمصطلحات موضوعية: Quality of life, MoCA, Montreal Cognitive Assessment, NCCN, National Comprehensive Cancer Network, R895-920, OAR, Organ At Risk, LINAC, Linear Accelerator, Stereotactic Brain RadioSurgery, Article, MRI, Magnetic Resonance Imaging, CRF, Case Report Form, MBM, Multiple Brain Metastastes, SRT, Stereotactic Radiation Therapy, Neurocognitive performance, Medical physics. Medical radiology. Nuclear medicine, Stereotactic Brain Radiotherapy, KPS, Karnofsky Performance Status, RT, Radiation Therapy, SRS, Stereotactic RadioSurgery, Radiology, Nuclear Medicine and imaging, RC254-282, QoL, Quality of Life, Radiotherapy for multiple brain metastases, EORTC QLQ-C15-PAL, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 for Palliative Care, QLQ-BN20, Quality of Life Questionnaire - Brain Neoplasm 20, VEGF, Vascular Endothelial Growth Factor, CT, Computerized Tomography, Whole Brain Radiotherapy, RTOG, Radiation Therapy Oncology Group, PTV, Planning Target Volume, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, SBI, Stereotactic Brain Irradiation, GTV, Gross Tumor Volume, Brain metastases, Supportive care in cancer patients, Neurocognitive tests, 3D-CRT, 3Dimensional-ConformalRadioTherapy, CTV, Clinical Target Volume, OS, Overall Survival, Oncology, Neurocognitive decay, BSC, Best Supportive Care, Palliative care, FSRT, Fractionated Stereotactic Radiation Therapy, Autonomy in daily activities, human activities
-
10
المؤلفون: Maud le Guyader, Daniel Lam Cham Kee, Mathieu Gautier, Marie-Eve Chand-Fouche, Renaud Schiappa, Brice Thamphya, Jean-Michel Hannoun-Levi
المصدر: Clinical and Translational Radiation Oncology, Vol 32, Iss, Pp 15-23 (2022)
Clinical and Translational Radiation Oncologyمصطلحات موضوعية: CT, computerized tomography, medicine.medical_treatment, Brachytherapy, R895-920, NCI, national cancer institute, FIGO, International Federation of Gynecology and Obstetrics, Medical physics. Medical radiology. Nuclear medicine, CTCAE, common terminology criteria for adverse events, EBRT, external beam radiotherapy, Surveillance, Epidemiology, and End Results, NFS, nodal recurrence-free survival, Original Research Article, IGABT, image-guided adaptative brachytherapy, CTV, clinical target volume, HR, high-risk, RC254-282, Cervical cancer, Univariate analysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Common Terminology Criteria for Adverse Events, EMBRACE, image guided intensity modulated External beam radiochemotherapy and MRI based Adaptative BRAchytherapy in locally advanced CErvical cancer, EQD2Gy, equivalent dose at 2 Gy, IMRT, intensity modulated radiotherapy, pts, patients, PFS, progression-free survival, HIV, human immunodeficiency virus, SEER, surveillance, epidemiology and end results, LACC, locally advanced cervical cancer, Oncology, LDR, low-dose-rate, RCT, radio-chemotherapy, ESTRO, European Society for Radiotherapy and Oncology, PTV, planning target volume, GEC, groupe européen de curiethérapie, High-dose-rate, NA, not available, medicine.medical_specialty, GTV, gross tumor volume, MFU, median follow up, Urology, BED, biologically effective dose, PET, positron emission tomography, OS, overall survival, OTT, overall treatment time, BMI, body-mass index, Median follow-up, LFS, local recurrence-free survival, SCC, squamous cell cancer, medicine, MFS, metastatic recurrence-free survival, Radiology, Nuclear Medicine and imaging, External beam radiotherapy, Progression-free survival, ICRU, International Commission on Radiation Units and measurements, business.industry, PDR, pulsed-dose-rate, pt, patient, medicine.disease, OAR, organs at risk, HDR, high-dose-rate, IR, intermediate-risk, LQ, linear quadratic, BT, brachytherapy, Fractionation scheme, business, MRI, magnetic resonance imaging, BID, twice-a-day